The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
The woodchuck hepatitis virus post-transcriptional regulatory element reduces readthrough transcription from retroviral vectors
Abstract
The woodchuck hepatitis virus post-transcriptional regulatory element (WPRE) increases transgene expression from a variety of viral vectors, although the precise mechanism is not known. WPRE is most effective when placed downstream of the transgene, proximal to the polyadenylation signal. We hypothesized that WPRE likely reduces viral mRNA readthrough transcription by improving transcript termination, which in turn would increase viral titers and expression. Using a Cre-lox-mediated plasmid-based assay, we found significant readthrough transcription from gamma-retroviral vector (RV) long terminal repeat (wt RV-LTR) and RV LTR with a self-inactivating deletion (SIN RV-LTR). WPRE, when placed upstream of the RV LTRs, significantly reduced readthrough transcription. Readthrough, present at much lower levels with the SIN HIV-1 LV-LTR, was also reduced with WPRE. When placed in RV vectors, WPRE increased total RV genomic mRNA; and increased viral titers from transiently transfected 293T cells and stable PG13 producer cells by 7- to 15-fold. The mechanism of increased titers and expression was not due to increased nuclear mRNA export, increased rate of viral transcription or a significant increase in viral mRNA half-life. Our results showed that WPRE improved vector genomic transcript termination to increase titers and expression from RVs.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The woodchuck hepatitis post-transcriptional regulatory element (WPRE) is often included in AAV cassettes to improve viral titer and transduction efficiency via stabilizing mRNA and regulating transcriptional termination [26, 27].”
From Designing and optimizing AAV-mediated gene therapy for neurodegenerative diseases: from bench to bedside (2024) · cites this paper as [27]
Citations
Cites
In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral Vector
Naldini, L., Blömer, U., Gallay, P., Ory, D., Mulligan, R., Gage, F. H., Verma, I. M., & Trono, D. (1996) · Science · doi:10.1126/science.272.5259.263 · Cited by 4,903
Zufferey, R., Donello, J. E., Trono, D., & Hope, T. J. (1999) · Journal of Virology · doi:10.1128/jvi.73.4.2886-2892.1999 · Cited by 1,030
A transient three-plasmid expression system for the production of high titer retroviral vectors
Soneoka, Y., Cannon, P. M., Ramsdale, E. E., Griffiths, J. C., Romano, G., Kingsman, S. M., & Kingsman, A. J. (1995) · Nucleic Acids Research · doi:10.1093/nar/23.4.628 · Cited by 686
Woodchuck hepatitis virus contains a tripartite posttranscriptional regulatory element
Donello, J. E., Loeb, J. E., & Hope, T. J. (1998) · Journal of Virology · doi:10.1128/jvi.72.6.5085-5092.1998 · Cited by 350
Loeb, J. E., Cordier, W. S., Harris, M. E., Weitzman, M. D., & Hope, T. J. (1999) · Human Gene Therapy · doi:10.1089/10430349950016942 · Cited by 279
Inefficient processing impairs release of RNA from the site of transcription
Custódio, N., Carmo‐Fonseca, M., Geraghty, F., Periera, H. S., Grosveld, F. G., & Antoniou, M. N. (1999) · The EMBO Journal · doi:10.1093/emboj/18.10.2855 · Cited by 220
Schambach, A., Wodrich, H., Hildinger, M., Bohne, J., Kräusslich, H.-G., & Baum, C. (2000) · Molecular Therapy · doi:10.1006/mthe.2000.0191 · Cited by 194
Krall, W. J., Challita, P. M., Perlmutter, L., Skelton, D. C., & Kohn, D. B. (1994) · Blood · doi:10.1182/blood.v83.9.2737.2737 · Cited by 163
Self-citationHuang, Z., & Yen, T. S. B. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.7.3864 · Cited by 154
Schambach, A., Bohne, J., Baum, C., Hermann, F. G., Egerer, L., von Laer, D., & Giroglou, T. (2005) · Gene Therapy · doi:10.1038/sj.gt.3302698 · Cited by 145
Cited by
Sorted by citations
Beane, O. S., Fonseca, V. C., Cooper, L. L., Koren, G., & Darling, E. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0115963 · Cited by 325
Lentiviral Vectors to Probe and Manipulate the Wnt Signaling Pathway
Fuerer, C., & Nusse, R. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009370 · Cited by 283
Biosafety Features of Lentiviral Vectors
Schambach, A., Zychlinski, D., Ehrnstroem, B., & Baum, C. (2013) · Human Gene Therapy · doi:10.1089/hum.2012.229 · Cited by 173
Viral Vectors: The Road to Reducing Genotoxicity
David, R. M., & Doherty, A. (2016) · Toxicological Sciences · doi:10.1093/toxsci/kfw220 · Cited by 176
State-of-the-Art Lentiviral Vectors for Research Use: Risk Assessment and Biosafety Recommendations
Pauwels, K., Gijsbers, R., Toelen, J., Schambach, A., Willard-Gallo, K., Verheust, C., Debyser, Z., & Herman, P. (2009) · Current Gene Therapy · doi:10.2174/156652309790031120 · Cited by 106
New developments in lentiviral vector design, production and purification
Segura, M. M., Mangion, M., Gaillet, B., & Garnier, A. (2013) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2013.779249 · Cited by 127
Designing Lentiviral Vectors for Gene Therapy of Genetic Diseases
Poletti, V., & Mavilio, F. (2021) · Viruses · doi:10.3390/v13081526 · Cited by 111
CAR-T cell potency: from structural elements to vector backbone components
Mazinani, M., & Rahbarizadeh, F. (2022) · Biomarker Research · doi:10.1186/s40364-022-00417-w · Cited by 111
Emery, D. W. (2011) · Human Gene Therapy · doi:10.1089/hum.2010.233 · Cited by 98
Zanta, M.-A., Charrier, S., Brice-Ouzet, A., Martin, S., Opolon, P., Thrasher, A. J., Hope, T. J., & Galy, A. H. M. (2009) · Gene Therapy · doi:10.1038/gt.2009.3 · Cited by 89
Lin, P. Y., Lin, Y., Lennon, D. P., Correa, D., SCHLUCHTER, M. D., & Caplan, A. I. (2012) · Stem Cells Translational Medicine · doi:10.5966/sctm.2012-0086 · Cited by 83
Avoiding cytotoxicity of transposases by dose-controlled mRNA delivery
Galla, M., Schambach, A., Falk, C. S., Maetzig, T., Kuehle, J., Lange, K., Zychlinski, D., Heinz, N., Brugman, M. H., Göhring, G., et al. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr384 · Cited by 75
Use of HIV as a gene transfer vector.
Pluta, K. D., & Kacprzak, M. M. (2009) · Acta Biochimica Polonica · doi:10.18388/abp.2009_2490 · Cited by 76
Mechanism of Reduction in Titers From Lentivirus Vectors Carrying Large Inserts in the 3′LTR
Urbinati, F., Arumugam, P. I., Higashimoto, T., Perumbeti, A., Mitts, K., Xia, P., & Malik, P. (2009) · Molecular Therapy · doi:10.1038/mt.2009.89 · Cited by 69
Self-citationAdeno-Associated Viral Gene Therapy for Inherited Retinal Disease
Ong, T., Pennesi, M. E., Birch, D. G., Lam, B. L., & Tsang, S. H. (2019) · Pharmaceutical Research · doi:10.1007/s11095-018-2564-5 · Cited by 66
Avoiding cytotoxicity of transposases by dose-controlled mRNA delivery
Galla, M., Schambach, A., Falk, C. S., Maetzig, T., Kuehle, J., Lange, K., Zychlinski, D., Heinz, N., Brugman, M. H., Göhring, G., et al. (2012) · Nucleic Acids Research · doi:10.1093/nar/gkr1266 · Cited by 59
Patrício, M. I., Barnard, A. R., Orlans, H. O., McClements, M. E., & MacLaren, R. E. (2017) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2016.12.006 · Cited by 59
Transient Retrovirus-Based CRISPR/Cas9 All-in-One Particles for Efficient, Targeted Gene Knockout
Knopp, Y., Geis, F. K., Heckl, D., Horn, S., Neumann, T., Kuehle, J., Meyer, J., Fehse, B., Baum, C., Morgan, M. A., et al. (2018) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2018.09.006 · Cited by 63
Palfi, A., Millington‐Ward, S., Chadderton, N., O’Reilly, M., Goldmann, T., Humphries, M. M., Li, T., Wolfrum, U., Humphries, P., Kenna, P. F., et al. (2009) · Human Gene Therapy · doi:10.1089/hum.2009.119 · Cited by 56
Xu, L., Yao, S., Ding, Y. E., Xie, M., Feng, D., Sha, P., Tan, L., Bei, F., & Yao, Y. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05661-2 · Cited by 48
Ottaviano, G., & Qasim, W. (2025) · Leukemia · doi:10.1038/s41375-025-02585-8 · Cited by 45
Genetic Therapy for Beta-Thalassemia: From the Bench to the Bedside
Arumugam, P. I., & Malik, P. (2010) · Hematology · doi:10.1182/asheducation-2010.1.445 · Cited by 41
Self-citationGenetic modification of lymphocytes by retrovirus-based vectors
Suerth, J. D., Schambach, A., & Baum, C. (2012) · Current Opinion in Immunology · doi:10.1016/j.coi.2012.08.007 · Cited by 38
Zeng, J., Du, J., Lin, J., Bak, X. Y., Wu, C., & Wang, S. (2009) · Molecular Therapy · doi:10.1038/mt.2009.124 · Cited by 38
Evolving Lessons on Nanomaterial-Coated Viral Vectors for Local and Systemic Gene Therapy
Kasala, D., Yoon, A. R., Hong, J., Kim, S. W., & Yun, C. (2016) · Nanomedicine · doi:10.2217/nnm-2016-0060 · Cited by 38
Larson, S. M., Truscott, L. C., Chiou, T., Patel, A., Kao, R. L., Tu, A. A., Tyagi, T., Lü, X., Elashoff, D. A., & Oliveira, S. N. D. (2017) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2016.1268745 · Cited by 32
Strategies to improve safety profile of AAV vectors
Suoranta, T., Laham-Karam, N., & Ylä‐Herttuala, S. (2022) · Frontiers in Molecular Medicine · doi:10.3389/fmmed.2022.1054069 · Cited by 32
The transformative potential of HSC gene therapy as a genetic medicine
Sagoo, P., & Gaspar, H. B. (2021) · Gene Therapy · doi:10.1038/s41434-021-00261-x · Cited by 27
Grinshpun, A., Condiotti, R., Waddington, S. N., Peer, M., Zeig, E., Peretz, S., Simerzin, A., CHOU, J. Y., Pan, C., Giladi, H., et al. (2010) · Molecular Therapy · doi:10.1038/mt.2010.119 · Cited by 29
Sustained Expression from DNA Vectors
Wong, S. P., Argyros, O., & Harbottle, R. P. (2014) · Advances in genetics · doi:10.1016/bs.adgen.2014.11.002 · Cited by 26
The design of retroviral vectors used in the CAR‐T products, risk management, and future perspective
Yin, H., & Wei, X. (2025) · MedComm · doi:10.1002/mco2.70067 · Cited by 27
McKee, K. K., & Yurchenco, P. D. (2022) · JCI Insight · doi:10.1172/jci.insight.158397 · Cited by 23
Chu, T. L., Chen, P., Yu, A. X., Kong, M., Tan, Z., Tsang, K. Y., Zhou, Z., & Cheah, K. S. E. (2023) · eLife · doi:10.7554/elife.82142 · Cited by 20
Boulaire, J., Balani, P., & Wang, S. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.02.007 · Cited by 22
Genetically engineered birds; pre-CRISPR and CRISPR era
Dehdilani, N., Taemeh, S. Y., Goshayeshi, L., & Dehghani, H. (2021) · Biology of Reproduction · doi:10.1093/biolre/ioab196 · Cited by 21
Advances in Recombinant Adeno-Associated Virus Vectors for Neurodegenerative Diseases
Li, L., Vasan, L., Kartono, B., Clifford, K. P., Attarpour, A., Sharma, R., Mandrozos, M., Kim, A., Zhao, W., Belotserkovsky, A., et al. (2023) · Biomedicines · doi:10.3390/biomedicines11102725 · Cited by 19
Generation of High-Titer Self-Inactivated γ-Retroviral Vector Producer Cells
Ghani, K., Boivin-Welch, M., Roy, S., Piaceski, A. D., Barbier, M. A., Pope, E., Germain, L., & Caruso, M. (2019) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2019.05.013 · Cited by 20
Prevention of transgene silencing during human pluripotent stem cell differentiation
Uenaka, T., Napole, A., Saha, A., Sun, D., Singavarapu, A., Calzada, E., Chen, J., Erlebach, L., McQuade, A., Ramos, D. M., et al. (2026) · Cell stem cell · doi:10.1016/j.stem.2026.01.007 · Cited by 21
Kitazawa, T., Minoux, M., Ducret, S., & Rijli, F. M. (2022) · Journal of Developmental Biology · doi:10.3390/jdb10010009 · Cited by 16
Chen, X., Gao, W., Gambotto, A. A., & Finn, O. J. (2008) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-008-0624-0 · Cited by 15
HIV-1-Based Lentiviral Vectors
Liu, Y. P., & Berkhout, B. (2013) · Methods in molecular biology · doi:10.1007/978-1-62703-670-2_22 · Cited by 15
Lentiviral Vectors: From Wild-Type Viruses to Efficient Multi-Functional Delivery Vectors
Arrasate, A., Lopez-Robles, C., Zuazo, M., Baños-Mateos, S., Martín, C., Lamsfus‐Calle, A., & Fertin, M. J. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26178497 · Cited by 14
Elements of lentiviral vector design toward gene therapy for treating mucopolysaccharidosis I
Ou, L., Przybilla, M. J., Koniar, B. L., & Whitley, C. B. (2016) · Molecular Genetics and Metabolism Reports · doi:10.1016/j.ymgmr.2015.11.004 · Cited by 15
Develop an efficient and specific AAV-based labeling system for Muller glia in mice
Gao, Y., Fang, K., Yan, Z., Zhang, H., Geng, G., Wu, W., Ding, X., Zhang, H., Zhong, N., Wang, Q., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-27013-0 · Cited by 13
Improved microRNA suppression by WPRE-linked tough decoy microRNA sponges
Hollensen, A. K., Thomsen, R., Bak, R. O., Petersen, C. C., Ermegaard, E. R., Aagaard, L., Damgaard, C. K., & Mikkelsen, J. G. (2017) · RNA · doi:10.1261/rna.061192.117 · Cited by 15
Retrovirus-Based mRNA Transfer for Transient Cell Manipulation
Galla, M., Schambach, A., & Baum, C. (2012) · Methods in molecular biology · doi:10.1007/978-1-62703-260-5_10 · Cited by 13
ExportAid: database of RNA elements regulating nuclear RNA export in mammals
Giulietti, M., Milantoni, S. A., Armeni, T., Principato, G., & Piva, F. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btu620 · Cited by 12
Dodd, M., Marquez‐Curtis, L. A., Janowska‐Wieczorek, A., & Hortelano, G. (2014) · The Journal of Gene Medicine · doi:10.1002/jgm.2769 · Cited by 11
Comparison of Lentiviral Packaging Mixes and Producer Cell Lines for RNAi Applications
Albrecht, C. H., Hosiner, S., Tichy, B., Aldrian, S. M., Hajdú, Š., & Nürnberger, S. (2015) · Molecular Biotechnology · doi:10.1007/s12033-015-9843-8 · Cited by 10
Richard, É., Lalanne, M., Lamrissi‐Garcia, I., Guyonnet‐Dupérat, V., Richard, E., Pitard, V., Mazurier, F., Moreau‐Gaudry, F., Ged, C., & de Verneuil, H. (2010) · The Journal of Gene Medicine · doi:10.1002/jgm.1478 · Cited by 10
Fan, X., Truong, J. B., Okada, K., Lin, H., Ori-McKenney, K. M., & McKenney, R. J. (2026) · Communications Biology · doi:10.1038/s42003-026-10797-6 · Cited by 10
The Post-Transcriptional Regulatory Element of Hepatitis B Virus: From Discovery to Therapy
Mouzannar, K., Schauer, A., & Liang, T. J. (2024) · Viruses · doi:10.3390/v16040528 · Cited by 8
Luchicchi, A., Pattij, T., Viaña, J. N. M., de Kloet, S. F., & Marchant, N. J. (2020) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2020.109004 · Cited by 8
Neural development in human embryonic stem cells-applications of lentiviral vectors
Dottori, M., Tay, C. Y., & Hughes, S. M. (2011) · Journal of Cellular Biochemistry · doi:10.1002/jcb.23116 · Cited by 7
Lentiviral vectors with amplified β cell-specific gene expression
Shaw, K. L., Pais, E., Ge, S., Hardee, C. L., Skelton, D. C., Hollis, R. P., Crooks, G. M., & Kohn, D. B. (2009) · Gene Therapy · doi:10.1038/gt.2009.49 · Cited by 7
Self-citationOjiro, I., Katsuyama, H., Kaneko, R., Ogasawara, S., Murata, T., Terada, Y., & Ito, K. (2024) · PLoS ONE · doi:10.1371/journal.pone.0306029 · Cited by 6
Wright, J. H., Huang, L.-Y., Weaver, S., Archila, L. D., McAfee, M. S., Hirayama, A. V. V., Chapuis, A. G., Bleakley, M., Rongvaux, A., Turtle, C. J., et al. (2020) · Journal of Immunological Methods · doi:10.1016/j.jim.2020.112955 · Cited by 6
Wang, X.-Y., Zhang, W., Jia, Y., Wang, M., Yi, D., & Wang, T. (2020) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmaa105 · Cited by 6
Ali, A. M., Özdemirli, M., Hamilton, M. P., & Jain, M. D. (2026) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-026-01147-w · Cited by 7
Retroviral Vectors for Cell and Gene Therapy
Schambach, A., Maetzig, T., & Baum, C. (2008) · CRC Press eBooks · doi:10.1201/9780849387999.pt1 · Cited by 5
Plugging synthetic DNA nanoparticles into the central dogma of life
Neyra, K., Desai, S., & Mathur, D. (2024) · Chemical Communications · doi:10.1039/d4cc04648j · Cited by 4
Obeid, M., Akkawi, R., Repudi, S., Singh, P. K., Abudiab, B., Jebara, T., Berent, A., Brennan, T., Weiss, Y., Shekh‐Ahmad, T., et al. (2026) · Molecular Therapy Advances · doi:10.1016/j.omta.2026.201791 · Cited by 4
Andrés‐Mateos, E., Kozlowski, C., Zhang, H., Fajardo, D., Xu, E. M., Navas‐Enamorado, I., Calabro, K. R., Rayaprolu, S., Havlik, L. P., Handy, T. E., et al. (2026) · Molecular Therapy · doi:10.1016/j.ymthe.2026.03.014 · Cited by 4
Adenovirus 5 Vectors Expressing SARS-CoV-2 Proteins
Bachus, S., Akkerman, N., Fulham, L., Graves, D., Stephanson, C., Memon, H., Miller, M. S., & Pelka, P. (2022) · mSphere · doi:10.1128/msphere.00998-21 · Cited by 3
Zhou, X., Liu, Q., Wang, D., Zhang, X., Emery, D. W., & Li, C. L. (2017) · Cytogenetic and Genome Research · doi:10.1159/000464315 · Cited by 3
Bauer, G., & Anderson, J. S. (2014) · SpringerBriefs in biochemistry and molecular biology · doi:10.1007/978-1-4939-0434-1_4 · Cited by 3
Goldman, C., Kareva, T., Sarrafha, L., Schuldt, B. R., Sahasrabudhe, A., Ahfeldt, T., & Blanchard, J. (2025) · iScience · doi:10.1016/j.isci.2025.112816 · Cited by 4
Humanized extracellular vesicles for efficient RNA delivery
Ma, X., Zhao, S. R., & Cepko, C. L. (2026) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2525726123 · Cited by 2
Meganck, R. M., Ogurlu, R., Liu, J., Møller-Tank, S., Tse, L. V., Blondel, L. O., Rosales, A., Hall, A. C., Vincent, H. A., Moorman, N. J., et al. (2024) · Journal of Virology · doi:10.1128/jvi.00095-24 · Cited by 2
Ma, J., Meyer, S., Olweus, J., Jin, C., & Yu, D. (2024) · Immuno-Oncology Technology · doi:10.1016/j.iotech.2024.101031 · Cited by 2
Dady, A., Davidson, L., Loyer, N., Rappich, S., Findlay, G. M., Sanders, T., Januschke, J., & Storey, K. G. (2025) · Development · doi:10.1242/dev.205082 · Cited by 2
Jäschke, N. M., & Büning, H. (2022) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2022.04.002 · Cited by 2
Müller, L., Milsom, M. D., & Williams, D. A. (2010) · Springer eBooks · doi:10.1007/978-1-4419-7656-7_6 · Cited by 2
Jones, A., Massey, S. E., Zhang, D., Deigin, Y., & Quay, S. C. (2022) · Applied Microbiology · doi:10.3390/applmicrobiol2040068 · Cited by 2
Retroviral Integration Target Site Selection
Ciuffi, A., & Bushman, F. D. (2011) · Wiley eBooks · doi:10.1002/9781118015377.ch5 · Cited by 2
Development of viral & non-viral episomal vectors for gene therapy applications
Kymäläinen, H. (2012) · OpenGrey (Institut de l'Information Scientifique et Technique) · Cited by 2
Pullarkat, S., Black, G., Bleakley, M., Buenrostro, D., Chapuis, A. G., Hirayama, A. V. V., Jaeger-Ruckstuhl, C. A., Kimble, E. L., Lee, B. M., Maloney, D. G., et al. (2024) · PLoS ONE · doi:10.1371/journal.pone.0303057 · Cited by 1
Enhancing human ACE2 expression in mouse models to improve COVID ‐19 research
Jiaoyang, S., Shaofei, C., Guangliang, H., Xiongzhi, Q., Haofeng, L., Rui, M., Grillari, J., Zheng‐Li, S., Jiekai, C., Meiqin, L., et al. (2024) · FEBS Open Bio · doi:10.1002/2211-5463.13934 · Cited by 1
Tsachaki, M., Peltret, M., Laplace, T. B., Vaxelaire-Hily, E., Mosbaoui, F., Aillerie, C., Schmid, A., Galea, A., Contarin, F., Duarte, L., et al. (2026) · New Biotechnology · doi:10.1016/j.nbt.2026.03.008 · Cited by 1
Structural basis of lipid-dependent allosteric gating mechanisms for PC1-PC2 ion channel
Chen, M., Wang, Z., Shi, Y., Huang, G., Morais, T. D. C., Pillai, A., Wang, Y., Mou, M. A., Jing, D., Fan, R., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-75084-8 · Cited by 1
Dady, A., Davidson, L., Loyer, N., Rappich, S., Findlay, G. M., Sanders, T., Januschke, J., & Storey, K. G. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.05.01.591467 · Cited by 1
Transcription, Translation, and the Control of Gene Expression in Mammalian Cells
Mullick, A., & Massie, B. (2010) · Wiley eBooks · doi:10.1002/9780470054581.eib565
PROTEASOME INHIBITION ENHANCES THE EFFECT OF BIKDD GENE THERAPY
Sun, Y. (2014) · Digital Commons-TMC (Texas Medical Center)
Strategies for Restoring Vision by Transducing a Channelrhodopsin Gene into Retinal Ganglion Cells
Tomita, H., & Sugano, E. (2017) · Cambridge University Press eBooks · doi:10.1017/9781107281875.028
The WPRE improves genetic engineering with site-specific nucleasesPreprint
Ong, J. M., Brown, C. R., Mendel, M. C., & Cost, G. J. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/126904
Foamy virus vector integration and application in gene therapy
Sweeney, N. P. (2015) · Spiral (Imperial College London) · doi:10.25560/50704
Digital Droplet PCR Method for the Quantification of AAV Transduction Efficiency in Murine Retina
Okan, I. C. T., Ahmadian, M., Tutuncu, Y., Altay, H. Y., & Ağca, C. (2021) · Journal of Visualized Experiments · doi:10.3791/63038
Jones, A., Massey, S. E., Zhang, D., Deigin, Y., & Quay, S. C. (2022) · Research Square · doi:10.21203/rs.3.rs-1836803/v1
Jones, A., Massey, S. E., Zhang, D., Deigin, Y., & Quay, S. C. (2022) · Research Square · doi:10.21203/rs.3.rs-1836803/v2
Goldman, C., Kareva, T., Sarrafha, L., Schuldt, B. R., Sahasrabudhe, A., Ahfeldt, T., & Blanchard, J. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.4886465
Jin, H., Cho, Y. R., & Jung, Y. T. (2025) · Acta Virologica · doi:10.3389/av.2025.14262
de Silly, R. V., Seijo, B., Maillard, J., Reichenbach, P., & Irving, M. B. (2025) · NAR Molecular Medicine · doi:10.1093/narmme/ugaf030
NATO3 protects dopaminergic neurons in mouse in vivo and human in vitro Parkinson’s disease modelsPreprint
Valencia-Alarcón, E. P., Duret, L. C., Kobayashi, E., Cattaneo, O., Schneider, B. L., & Nagoshi, E. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.10.10.681573
Investigation of the effects of virus integration on host gene expression in mouse tumour samples
Osejindu, E. (2011) · Brunel University Research Archive (BURA) (Brunel University London)
Wright, J., Alberts, B. M., Quiles, M. L. M., Guarino, A., Chipchase, D., Clarkson, N. G., Mitrophanous, K. A., & Farley, D. C. (2025) · Molecular Therapy Advances · doi:10.1016/j.omta.2025.201654
AAV-TNNI3 rescues an experimental murine Tnni3 mutation resulting in thin filament mediated DCM
Bushway, P., Feng, W., Cruz, M. S., Maisel, S., Shathaya, A., Rao, P., Patel, U., Park, J., Chen, C., Tang, Z., et al. (2026) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2026.01.001
Optimisation de la stratégie de thérapie génique par vecteur lentiviral pour la β-thalassémie
Giorgi, M. (2019) · theses.fr (ABES) · doi:10.70675/041f272dz23faz452bzb352z46cf95acb76d
Coppens-Exandier, H., Mackanga, F., Darde, T., Bonhomme, C., Angenard, G., Leroyer, P., Ribault, C., Gicquel, T., Pelletier, R., Roshchina, F., et al. (2026) · Archives of Toxicology · doi:10.1007/s00204-026-04453-5
Highly Efficient Lentiviral Transduction of Human iPSC-Derived Microglia and MacrophagesPreprint
Goberdhan, S. C., Czubala, M. A., Thomas, S. E., Taylor, P. R., & Connor‐Robson, N. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.23.727402
Polymerizing laminins: Assembly, functions and disorders
Yurchenco, P. D. (2026) · Matrix Biology · doi:10.1016/j.matbio.2026.102031
Metadata
- Authors
- Higashimoto, T., Urbinati, F., Perumbeti, A., Jiang, G., Zarzuela, A., Chang, L.-J., Kohn, D. B., & Malik, P.
- Affiliations
- University of Southern California (US)
- University of Florida (US)
- Corresponding author
- Malik, P
- Venue
- Gene Therapy
- Published
- 2007-06-28
- Volume
- 14
- Issue
- 17
- Pages
- 1298-1304
- ISSN
- 0969-7128 (ISSN-L)
- 1476-5462
- OpenAlex
- W1975554944
- Cited by
- 101
- References
- 34
- Citations by year
- 2026: 13 · 2025: 9 · 2024: 10 · 2023: 2 · 2022: 10 · 2021: 4 · 2020: 3 · 2019: 3 · 2018: 1 · 2017: 6 · 2016: 3 · 2015: 2 · 2014: 6 · 2013: 3 · 2012: 5
- FWCI
- 2.86
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Gene Therapy (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5u54hl070595-05)
- National Heart, Lung, and Blood Institute (P01HL073104, U54-HL070595, R01-HL70135-01, R01HL070135)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Viral Infectious Diseases and Gene Expression in Insects
- Keywords
- read-through transcription, retroviral vectors, long terminal repeat, HIV-1 long terminal repeat, viral titer, transgene expression, polyadenylation signal
- MeSH terms
- Animals, Cell Line, Genetic Engineering, Genetic Vectors, Humans, Leukemia Virus, Murine, Retroviridae, RNA Processing, Post-Transcriptional, Transcription, Genetic, Transfection, Simian Immunodeficiency Virus, Gene Expression, Gene Expression Regulation, Viral, Reading Frames, Hepatitis B Virus, Woodchuck, Transgenes, Terminal Repeat Sequences, Regulatory Elements, Transcriptional
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review